Roy Strom

April 01, 2017 | The American Lawyer

Before Stewart Dolin's suicide in 2010, he told his therapist he felt inadequate as a Reed Smith practice leader. It's a feeling therapists say that lawyers, as a group, often struggle with, especially following mergers. But Big Law has a zip-lipped culture when it comes to mental health concerns.

By Roy Strom

39 minute read

March 31, 2017 | The American Lawyer

"Americans deserve a president of undivided loyalty," the Wallace Global Fund told Morgan Lewis' leader. "Your firm has denied them that."

By Roy Strom

39 minute read

March 27, 2017 | The American Lawyer

Hourly rates are rebounding strongly from the post-recession doldrums and Big Law is leading the way in capturing more money for their time. Nonetheless, overall demand for lawyers' time continues to fall, according to an analysis released Monday of actual legal invoices from nearly 100 companies.

By Roy Strom

12 minute read

March 22, 2017 | The American Lawyer

Responding to legal threats by Detroit Mayor Mike Duggan, Jones Day's managing partner vigorously defended the firm's work on behalf of the Motor city and called its top elected official a "political hack."

By Roy Strom

29 minute read

March 22, 2017 | The American Lawyer

Psychiatrist David Healy has railed against GlaxoSmithKline and other pharmaceutical firms' clinical studies for years. Despite GSK's lawyers' best efforts, he did so again in Chicago this week as an expert in a trial over the 2010 suicide of a former Reed Smith practice leader.

By Roy Strom

17 minute read

March 19, 2017 | The American Lawyer

Stewart Dolin, a leader of Reed Smith's corporate department, committed suicide in 2010. His widow seeks $12 million for his death, alleging it was the result of an antidepressant whose suicidal side effects were covered up by GlaxoSmithKline. The pharmaceutical giant claims that Dolin's death was the result of an unpleasant work environment.

By Roy Strom

42 minute read

March 14, 2017 | The American Lawyer

Burford Capital Ltd. announced another banner financial year Tuesday, with profit after tax rising 75 percent from the year prior as the publicly traded litigation funder committed $378 million to new investments, a yearly increase of 83 percent.

By Roy Strom

9 minute read

March 14, 2017 | International Edition

Most major law firm combinations since 2000 have not resulted in significant growth, according to a new report

By Roy Strom

4 minute read

March 13, 2017 | The American Lawyer

In the first deal of its kind, Burford Capital Ltd. is poised to make a 91 percent return on its $26 million purchase of a portion of a bankruptcy judgment. Burford will likely collect $50 million after an appeals court affirmed the $213 million judgment the litigation funder bought into.

By Roy Strom

7 minute read

March 10, 2017 | The American Lawyer

A traumatic departure of more than 20 partners and a $32 million contingent fee earned in 2015 conspired to send gross revenue plummeting to $222 million at Schiff Hardin last year.

By Roy Strom

19 minute read